USPTO serial 76360216
Serial No. 76360216
Reviewed by CopyMark Law Group
Reg. 2901062Status 710
- Filing date
- Status date
- Registration date
- Nov 9, 2004
- Examiner
- DEFORD, JEFFREY S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 76360216?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical linkers, purines, pyrimidines, nucleic acids, nucleotides, nucleosides, natural and synthetic nucleic acids namely, DNA, proteins, peptides and small organic molecules and reagents for scientific and medical research use; chemicals, organic and inorganic molecules for use in connection with, and for the manufacture of, arrays, microarrays, labeling reagents and chips for use in nucleic acid analysis and the synthesis of nucleic acids, nucleotides, nucleosides and other organic molecules; biological materials for scientific and medical research, namely, natural nucleic acid and synthetic nucleic acid namely DNA, nucleosides, nucleotides, proteins, peptides and small organic molecules, human, plant and animal tissues, proteins, antibodies, nucleic acids, plant and animal cells, viruses, pathogens, bacteria, fungi, synthetic materials for scientific and medical research, namely synthetic DNA, synthetic nucleic acids, modified purines, pyrimidines, nucleotides, nucleosides, plants and animal cells, viruses, pathogens, bacteria, fungi, human, plant and animal tissues, proteins, peptides, small organic molecules and antibodies | SECTION 8 - CANCELLED | — |
| 005 | Chemicals, reagents and biological tissues for medical, veterinary and diagnostic use, namely, chemical linkers, natural and synthetic nucleic acids namely DNA, purines, pyrimidines, nucleosides, nucleotides, proteins, peptides and small organic molecules, human plant and animal tissues, proteins, antibodies, nucleic acids, plant and animal cells, plant and animal cell lines, viruses, pathogens, bacteria, fungi; chemicals, reagents and biological tissues for use with micro arrays for medical, veterinary and diagnostic use, namely, chemical linkers, natural and synthetic nucleic acids, namely DNA, purines, pyrimidines, nucleosides, nucleotides, proteins, peptides and small organic molecules, human, plant and animal tissues, proteins, antibodies, nucleic acids, plant and animal cells, plant and animal cell lines, viruses, pathogens, bacteria, fungi; natural and synthetic nucleic acids, deoxyribose nucleic acids for medical, veterinary and clinical laboratory and diagnostic use; fluorescent labels for medical, medical analysis, clinical, veterinary and diagnostic use, enzymes for medical, veterinary and clinical laboratory and diagnostic use | SECTION 8 - CANCELLED | — |
| 009 | Diagnostic testing apparatus and instruments namely, microscopes, lasers, cameras, fluidic work stations, scanners, chips and automated chemistry analyzers for the testing, analysis and examination of biological materials, automated clinical chemistry analyzers, machines, for testing, analyzing and examining biological materials, all for the scientific and research use; Scientific apparatus and instruments for testing, analyzing and the examination of nucleic acids, nucleotides, nucleosides, proteins, peptides and small organic molecules and other biological materials, namely microscopes, lasers, cameras, fluidic workstations, scanners, chips and automated clinical chemistry analyzers, all for scientific and research use; Automated apparatus and instruments, namely, microscopes, lasers, cameras, fluidic workstations, chips and scanners for scientific and research use; Computer programs and software for data reduction, computer programs and software for image processing and signal interpretation, computer programs and software for testing, analyzing and examining biological material; computer programs and software for the analysis, examination and testing of biological materials in the field of genetics and nucleic acid namely DNA analysis; computer software for sequence analysis and annotation; computer software for controlling imaging, fluidics, scanning, focusing and robotics; storage media, namely floppy discs, DVDs, CD-ROMS, CD-Rs, CD-RWs, tape drives and compact discs featuring information on biological materials, genes, expressed sequences and genetic variations of said genes and expressed sequences, genetics, nucleic acids, nucleotides, nucleosides, proteins and peptides, phenotype data and other organic molecules, Electronic databases relating to the field of genetics and DNA analysis recorded on computer media, blank floppy discs for computers. | SECTION 8 - CANCELLED | — |
| 010 | Medical diagnostic testing apparatus and instruments, namely, surgical probes and surgical chips | SECTION 8 - CANCELLED | — |
| 040 | Deposition of synthetic, organic or inorganic chemical and biological reagents on substrates, slides, and scientific apparatus and instruments, namely, microscopes, arrays, microarrays, lasers, cameras, fluidic workstations, scanners, chips and automated clinical chemistry analyzers for the testing, analysis and examination of biological materials; chemical processing of substrates, slides and scientific apparatus and instruments in the preparation of arrays and microarrays | SECTION 8 - CANCELLED | — |
| 042 | Scientific and medical research and product development; genetic analysis services for others, nucleic acid namely DNA and other biological matter analysis services for others, nucleic acid sequence analysis, proteome analysis services; Design for others of computer programs, Preparation of medical reports for others relating to genetic analysis; diagnostic testing services; medical and scientific research, namely conducting of clinical trials, licensing of intellectual property, namely research and development and patented technology, providing an on-line computer database in the field of genetics; consulting services in the medical, biological and scientific research and product development fields | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Solexa Limited
- Other trademarks owned by Solexa Limited
- Other trademarks owned by Solexa Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 23, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 9, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| May 19, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2003 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 24, 2003 | CFIT | CASE FILE IN TICRS | — |
| May 15, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2003 | PAPER RECEIVED | — | |
| Dec 6, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 6, 2002 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |